190.95
-5.99 (-3.04%)
| Penutupan Terdahulu | 196.94 |
| Jumlah Dagangan | 5,934,275 |
| Harga / Jualan (P/S) | 9.04 |
| Harga / Buku (P/B) | 15.65 |
| Julat 52 Minggu |
| EPS Cair (TTM) | -4.01 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.46% |
| Nisbah Semasa (MRQ) | 13.46 |
| Aliran Tunai Operasi (OCF TTM) | -591.31 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -349.13 M |
| Pulangan Atas Aset (ROA TTM) | -23.09% |
| Pulangan Atas Ekuiti (ROE TTM) | -36.68% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menaik |
| Biotechnology (Global) | Bercampur | Menaik | |
| Stok | Revolution Medicines, Inc. | Bercampur | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | NA |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -0.5 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | -0.5 |
| Purata | -1.75 |
|
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 2.02% |
| % Dimiliki oleh Institusi | 105.87% |
Tiada data dalam julat masa ini.
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| KELSEY STEPHEN MICHAEL | - | 203.77 | -92,531 | -18,855,042 |
| KIM LORENCE H. | - | 207.32 | -17,090 | -3,543,099 |
| MANCINI ANTHONY | - | 203.35 | -15,448 | -3,141,351 |
| Jumlah Keseluruhan Kuantiti Bersih | -125,069 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -25,539,491 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 204.81 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| KELSEY STEPHEN MICHAEL | Pegawai | 11 Sep 2026 | Jual automatik (-) | 92,531 | 203.77 | 18,855,042 |
| KELSEY STEPHEN MICHAEL | Pegawai | 11 Sep 2026 | Pelaksanaan pilihan | 92,531 | - | - |
| MANCINI ANTHONY | Pegawai | 10 Sep 2026 | Jual automatik (-) | 15,448 | 203.35 | 3,141,351 |
| MANCINI ANTHONY | Pegawai | 10 Sep 2026 | Pelaksanaan pilihan | 9,363 | - | - |
| KIM LORENCE H. | Pengarah | 08 Sep 2026 | Jual automatik (-) | 17,090 | 207.32 | 3,543,099 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |